Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Menstrual disorders associated with hyperprolactinemia.

A Caufriez

    Hormone Research
    |January 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Hyperprolactinemia frequently causes menstrual disorders by disrupting hormone secretion and potentially affecting fertilization and implantation. This hormonal imbalance impacts reproductive health through various mechanisms.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Hormonal replacement therapy (HRT) in postmenopause: a reappraisal.

    Annales d'endocrinologie·2007
    Same author

    Prolonged oral treatment with MK-677, a novel growth hormone secretagogue, improves sleep quality in man.

    Neuroendocrinology·1998
    Same author

    The pubertal spurt: effects of sex steroids on growth hormone and insulin-like growth factor I.

    European journal of obstetrics, gynecology, and reproductive biology·1997
    Same author

    Effects of a 7-day treatment with a novel, orally active, growth hormone (GH) secretagogue, MK-677, on 24-hour GH profiles, insulin-like growth factor I, and adrenocortical function in normal young men.

    The Journal of clinical endocrinology and metabolism·1996
    Same author

    Effects of bedtime administration of zolpidem on circadian and sleep-related hormonal profiles in normal women.

    Sleep·1995
    Same author

    Regulation of maternal insulin-like growth factor I by placental growth hormone in pregnancy. Possible action of maternal IGF-I on fetal growth.

    Hormone research·1994

    Area of Science:

    • Reproductive Endocrinology
    • Neuroendocrinology
    • Gynecology

    Background:

    • Hyperprolactinemia, elevated prolactin levels, is associated with frequent menstrual irregularities.
    • These disorders include irregular bleeding, luteal phase defects, and amenorrhea.

    Purpose of the Study:

    • To elucidate the mechanisms by which hyperprolactinemia induces menstrual dysfunction.
    • To explore the impact of hyperprolactinemia on hormonal regulation and reproductive processes.

    Main Methods:

    • Review of existing literature on hyperprolactinemia and menstrual disorders.
    • Analysis of hormonal pathways affected by elevated prolactin levels.

    Main Results:

    • Hyperprolactinemia disrupts hypothalamic LHRH secretion, impacting LH and sex steroid production.

    Related Experiment Videos

  • Elevated prolactin may directly interfere with ovarian function and endometrial receptivity.
  • Fertilization and implantation processes can be impaired by hyperprolactinemia.

    • Conclusions:

    • Hyperprolactinemia contributes to a spectrum of menstrual disorders through complex neuroendocrine and direct reproductive effects.
    • Understanding these mechanisms is crucial for managing reproductive health in affected individuals.